Does delayed EBV infection contribute to rising childhood cancers?
- 8 October 2022
- journal article
- editorial
- Published by Elsevier in Trends in Immunology
- Vol. 43 (12) , 956-958
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Science, ICT and Future Planning (2022010191)
- Daegu Gyeongbuk Institute of Science and Technology
- American Cancer Society (RSG-19–035–01-LIB)
- Leukemia and Lymphoma Society (TRP-6595–20)
This publication has 14 references indexed in Scilit:
- Mechanism of EBV inducing anti-tumour immunity and its therapeutic useNature, 2020
- Changing geographical patterns and trends in cancer incidence in children and adolescents in Europe, 1991–2010 (Automated Childhood Cancer Information System): a population-based studyThe Lancet Oncology, 2018
- A causal mechanism for childhood acute lymphoblastic leukaemiaNature Reviews Cancer, 2018
- Mechanisms of clonal evolution in childhood acute lymphoblastic leukemiaNature Immunology, 2015
- Sustained Complete Responses in Patients With Lymphoma Receiving Autologous Cytotoxic T Lymphocytes Targeting Epstein-Barr Virus Latent Membrane ProteinsJournal of Clinical Oncology, 2014
- Age-Specific Prevalence of Epstein–Barr Virus Infection Among Individuals Aged 6–19 Years in the United States and Factors Affecting Its AcquisitionThe Journal of Infectious Diseases, 2013
- Epstein-Barr Virus: An Important Vaccine Target for Cancer PreventionScience Translational Medicine, 2011
- Lymphocryptovirus phylogeny and the origins of Epstein-Barr virusJournal of General Virology, 2009
- CD4+ T-cell clones recognizing human lymphoma-associated antigens: generation by in vitro stimulation with autologous Epstein-Barr virus–transformed B cellsBlood, 2009
- Day care in infancy and risk of childhood acute lymphoblastic leukaemia: findings from UK case-control studyBMJ, 2005